Spero Therapeutics Inc (SPRO)
0.9597
-0.04
(-3.84%)
USD |
NASDAQ |
Dec 20, 16:00
0.9568
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Market Cap: 52.32M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CytomX Therapeutics Inc | 85.30M |
| Castle Biosciences Inc | 770.48M |
| Arbutus Biopharma Corp | 608.27M |
| PTC Therapeutics Inc | 3.566B |
| Equillium Inc | 20.91M |
Market Cap Related Metrics
| PE Ratio | 12.00 |
| PS Ratio | 0.576 |
| PEG Ratio | 0.0171 |
| Price to Book Value | 0.7987 |
| Price | 0.9597 |
| Earnings Yield | 8.34% |
| PEGY Ratio | 0.0171 |
| Normalized PE Ratio | 12.00 |